Focus and Scope
JMIR Diabetes (JD) is a PubMed/PubMed Central- and Scopus-indexed journal (Citescore 2022: 3.4, Q2).
JMIR Diabetes focuses on technologies, medical devices, apps, engineering, informatics and patient education for diabetes prevention, self-management, care, and cure, to help people with diabetes. We also accept papers that do not have a digital health component but represent a significant innovation for diabetes prevention and care.
We publish original research, viewpoints, and reviews (both literature reviews and medical device/technology/app reviews) covering, for example, wearable devices and trackers, mobile apps, glucose monitoring (including emerging technologies such as Google contact lens), medical devices for insulin and metabolic peptide delivery, closed loop systems and artificial pancreas, telemedicine, web-based diabetes education and elearning, innovations for patient self-management and "quantified self", diabetes-specific EHR improvements, clinical or consumer-focused software, diabetes epidemiology and surveillance, crowdsourcing and quantified self-based research data, new sensors and actuators to be applied to diabetes.
As an Open Access journal, JMIR Diabetes is read by clinicians and patients alike and have (as all JMIR Publications journals) a focus on readable and applied science reporting the design and evaluation of health innovations and emerging technologies, as well as on diabetes prevention and epidemiology.